Animal Vaccines Market Poised For 5.2% CAGR, Reaching $15.2 Billion By 2030

(MENAFN- EIN Presswire)

Animal Vaccines Guide

WILMINGTON, DELAWARE, UNITED STATES, July 10, 2024 /EINPresswire / -- Animal vaccines market size was valued at $9.09 billion in 2020, and is projected to reach $15.20 billion by 2030, registering a CAGR of 5.2% from 2021 to 2030. Vaccines help develop naturally acquired immunity by stimulating the immune system with the help of either non-pathogenic organisms or by their immunogenic components. Animal vaccines are essential to increase the welfare of the animal and reduce the monetary loss of their owners. These consist of attenuated and subunit vaccines and are useful in the prevention of diseases through their mode of action. Animal vaccines are eco-friendly products that help reduce the use of antibiotics and risk of drug-resistant microorganisms. They help protect animal health by immunizing the animal from any particular disease. These vaccines are essential for animal well-being, production of food, and safety of public health. Animal vaccines is a component of a larger field of medicine called veterinary biologics (VB). These vaccines function by activating the immune system to avoid the onset of any disease. As animal treatment is costlier than animal vaccination, these products are cost-effective solutions for animal welfare. Animal vaccine products help in the prevention of animal diseases, increase in food productivity, and avoid transmission of zoonotic and foodborne infections to humans.

List of Key Players :
CEVA SANTÉ ANIMALE, VAXXINOVA GMBH, ROMVAC COMPANY S.A., MERCK & COMPANY INC., VIRBAC S.A, HYGIEIA BIOLOGICAL LABORATORIES, ANICON LABOR GMBH, .ZOETIS INC., BOEHRINGER INGELHEIM GMBH, SANOFI S.A.

Download Sample Report

By product type, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The attenuated vaccines segment dominated the market with maximum share, in 2020 in terms of revenue. These vaccines are used to provide immunity from various animal diseases. The prevention of diseases that affect commercial animal such as poultry and cattle is more important, as their products in the form of milk and meat can be consumed by humans, which can lead to foodborne diseases in case of infected animal.

By animal type, the animal vaccines market is segmented into companion animal, livestock animal, and aquaculture. The companion animal segment is further segmented into cats and dogs. The livestock animal segment is further classified into cattle, pigs, poultry, sheep, and others (goats, horses, asses, camel, and others). The companion animal segment is expected to be the fastest growing segment throughout the analysis period and accounted for almost one-third of the total share of the market in 2020. Companion animal are the ones that are kept for the company or protection of a person and most commonly adopted companion animal include cats, dogs, and bird. A large number of companion animals are present worldwide.

For Purchase Inquiry

By region, the animal vaccines market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The animal vaccines market witnessed a vast growth in North America and is expected to continue to dominate the market in the coming years. This is attributed to established veterinary organizational structures and concern amongst people to ensure animal health. Furthermore, the major key players of this market operate in North American region. Apart from the common factors that drive this market including increase in use of vaccines in companion animal, there are various other reasons that contribute to the market growth. For instance, Centers for Disease Control and Prevention (CDC) have stated a few regulations regarding entry of animal in North America, especially cats. Pet cats have to undergo an examination at ports of entry for ensuring that the pet bears no infectious diseases, especially zoonotic diseases. The pet cats have to be administered with rabies vaccine before entering any state in North America as many states require the proof of vaccination. Such regulations mandate the need for vaccination in North America, which further fuels the growth of the market.

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link:

Explore More Reprots:
Animal Vaccines Market:
Nasal Spray Market :
Skeletal Dysplasia Market :

About Allied Market Research

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry

Media Contact:

Contact Us:

David Correa

Wilmington, Delaware, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

...

Web:

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X

MENAFN10072024003118003196ID1108426246